All updated as on -
From 2024–2031, the worldwide market for human growth hormone is predicted to expand from an initial valuation of $5.67B at a CAGR (compound annual growth rate) of 14.3%.
The rising demand for growth hormones as a treatment for hormonal imbalance illnesses and general public understanding of their benefits are driving the industry forward. The most prominent names in pharmaceuticals and biotech are also investing much in research and development to develop and launch new hormone treatments. These treatments are fueling the expansion of the industry worldwide since they promise long-term effects with improved safety profiles. There has been a rise in the demand for hormone treatments due to the rising incidence of growth hormone shortages caused by congenital diseases, genetic abnormalities, brain injuries, and particular medicinal therapy.
Tissue growth, repair, and multiplication are all regulated by human growth hormone (HGH). It controls the processes of cell division, growth promotion, and cell repair in the body; it is a peptide hormone. During a person's formative years, HGH is crucial. Worldwide, growth hormone insufficiency is becoming more common. Inadequate production of growth hormone by the pituitary gland characterizes growth hormone deficit (GHD), a medical disorder. It causes a wide range of mental and physical problems in both children and adults.
From delayed puberty and stunted growth to decreased bone density, exhaustion, and a diminished quality of life in adulthood, GHD affects a person's health in every way. The global population is now more cognizant of the importance of therapy due to the rise in the prevalence of human growth problems. As a result, it seems like the future of the human growth hormone market is looking bright. A hormone produced by humans, human growth hormone aids in development, reproduction, and regeneration. The market is expected to see expansion due to the rising demand for growth hormone and the increasing awareness of its benefits in managing illnesses associated with hormonal imbalance.
Also, a lot of businesses are putting money into research and development to create a growth hormone that is both long-lasting and has fewer negative effects. A number of factors are contributing to the market's expansion: the prevalence of growth hormone deficiency-related illnesses, the increasing demand for anti-aging hormones, public and private initiatives to raise awareness of the condition, and robust productivity. Additional aspects that are expected to contribute to the expansion of the human growth hormone market include heightened awareness of the treatment process, an increase in the number of health issues, and a rise in neuropsychiatric cases. The high rate of publication of new novels on human growth hormone is anticipated to fuel the expansion of the human growth hormone market.
Markets around the world for human growth hormone may feel the effects of the COVID-19 pandemic. According to a Frontiers article, individuals with reduced growth hormone secretion are at increased risk for COVID-19, so it's important to address this risk in order to avoid the spread of this virus. People with Prader-Willi syndrome also need to be extra cautious to avoid contracting the COVID-19 virus. It may take longer to diagnose COVID-19 in people with Prader-Willi syndrome since they may not exhibit classic signs such a high temperature and may also have a higher-than-normal pain threshold. Severe COVID-19 sickness is more likely to occur in people with Turner syndrome. Every country's healthcare system has been hit hard by the COVID-19 pandemic. Patients and healthcare providers alike have encountered new challenges as a result of the global lockdown situation.
According to the guidelines, several GH-stimulation tests should be administered to individuals who have a valid clinical suspicion of GHD in order to confirm a correct diagnosis. Because serum GH and insulin-like growth factor-1 (IGF-1) values are utilized to back up treatment decisions, they also advise caution when interpreting these levels. The guidelines for the treatment of GHD are somewhat cautious, favoring only those procedures for which there is adequate evidence and which reduce risks to patients as much as feasible. Genetic testing, radiographic evaluation, biochemical evaluation of GHD using specific assays, sex steroid priming, and other GH axis tests are some of the most well-known diagnostic criteria, tests, and treatment recommendations.
Report Coverage
Global Human Growth Hormone research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Human Growth Hormone report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Human Growth Hormone competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Human Growth Hormone market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Human Growth Hormone market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Human Growth Hormone market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Novo Nordisk, Ferring BV, Eli Lilly And Company, Roche, Ipsen, Anhui Anke Biotechnology (Group) Co., Ltd., Pfizer Inc., Merck & Co., TEVA PHARMACEUTICAL INDUSTRIES., Novartis AG
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Human Growth Hormone market based on the below-mentioned segments:
Global Human Growth Hormone Market, By Distribution Channel
Hospital pharmacy
Retail pharmacy
Online Pharmacy
Global Human Growth Hormone market, By Application
Growth hormone deficiency
Prader-Willi syndrome
Turner syndrome
Small for gestational age (SGA)
Others
Global Human Growth Hormone Market, By Route of Administration
Oral
Intravenous
Intramuscular
Subcutaneous
Global Human Growth Hormone market, Regional Analysis
The rising demand for growth hormones as a treatment for hormonal imbalance illnesses and general public understanding of their benefits are driving the industry forward. The most prominent names in pharmaceuticals and biotech are also investing much in research and development to develop and launch new hormone treatments. These treatments are fueling the expansion of the industry worldwide since they promise long-term effects with improved safety profiles. There has been a rise in the demand for hormone treatments due to the rising incidence of growth hormone shortages caused by congenital diseases, genetic abnormalities, brain injuries, and particular medicinal therapy.
Tissue growth, repair, and multiplication are all regulated by human growth hormone (HGH). It controls the processes of cell division, growth promotion, and cell repair in the body; it is a peptide hormone. During a person's formative years, HGH is crucial. Worldwide, growth hormone insufficiency is becoming more common. Inadequate production of growth hormone by the pituitary gland characterizes growth hormone deficit (GHD), a medical disorder. It causes a wide range of mental and physical problems in both children and adults.
From delayed puberty and stunted growth to decreased bone density, exhaustion, and a diminished quality of life in adulthood, GHD affects a person's health in every way. The global population is now more cognizant of the importance of therapy due to the rise in the prevalence of human growth problems. As a result, it seems like the future of the human growth hormone market is looking bright. A hormone produced by humans, human growth hormone aids in development, reproduction, and regeneration. The market is expected to see expansion due to the rising demand for growth hormone and the increasing awareness of its benefits in managing illnesses associated with hormonal imbalance.
Also, a lot of businesses are putting money into research and development to create a growth hormone that is both long-lasting and has fewer negative effects. A number of factors are contributing to the market's expansion: the prevalence of growth hormone deficiency-related illnesses, the increasing demand for anti-aging hormones, public and private initiatives to raise awareness of the condition, and robust productivity. Additional aspects that are expected to contribute to the expansion of the human growth hormone market include heightened awareness of the treatment process, an increase in the number of health issues, and a rise in neuropsychiatric cases. The high rate of publication of new novels on human growth hormone is anticipated to fuel the expansion of the human growth hormone market.
Markets around the world for human growth hormone may feel the effects of the COVID-19 pandemic. According to a Frontiers article, individuals with reduced growth hormone secretion are at increased risk for COVID-19, so it's important to address this risk in order to avoid the spread of this virus. People with Prader-Willi syndrome also need to be extra cautious to avoid contracting the COVID-19 virus. It may take longer to diagnose COVID-19 in people with Prader-Willi syndrome since they may not exhibit classic signs such a high temperature and may also have a higher-than-normal pain threshold. Severe COVID-19 sickness is more likely to occur in people with Turner syndrome. Every country's healthcare system has been hit hard by the COVID-19 pandemic. Patients and healthcare providers alike have encountered new challenges as a result of the global lockdown situation.
According to the guidelines, several GH-stimulation tests should be administered to individuals who have a valid clinical suspicion of GHD in order to confirm a correct diagnosis. Because serum GH and insulin-like growth factor-1 (IGF-1) values are utilized to back up treatment decisions, they also advise caution when interpreting these levels. The guidelines for the treatment of GHD are somewhat cautious, favoring only those procedures for which there is adequate evidence and which reduce risks to patients as much as feasible. Genetic testing, radiographic evaluation, biochemical evaluation of GHD using specific assays, sex steroid priming, and other GH axis tests are some of the most well-known diagnostic criteria, tests, and treatment recommendations.
Report Coverage
Global Human Growth Hormone research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Human Growth Hormone report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Human Growth Hormone competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Human Growth Hormone market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Novo Nordisk, Ferring BV, Eli Lilly And Company, Roche, Ipsen, Anhui Anke Biotechnology (Group) Co., Ltd., Pfizer Inc., Merck & Co., TEVA PHARMACEUTICAL INDUSTRIES., Novartis AG |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Human Growth Hormone Market from 2021 to 2031.
- Market Forecast for Human Growth Hormone Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Human Growth Hormone competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Human Growth Hormone
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Human Growth Hormone market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Human Growth Hormone market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Novo Nordisk, Ferring BV, Eli Lilly And Company, Roche, Ipsen, Anhui Anke Biotechnology (Group) Co., Ltd., Pfizer Inc., Merck & Co., TEVA PHARMACEUTICAL INDUSTRIES., Novartis AG
Primary Target Market
- Market Players of Human Growth Hormone
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Human Growth Hormone market based on the below-mentioned segments:
Global Human Growth Hormone Market, By Distribution Channel
Hospital pharmacy
Retail pharmacy
Online Pharmacy
Global Human Growth Hormone market, By Application
Growth hormone deficiency
Prader-Willi syndrome
Turner syndrome
Small for gestational age (SGA)
Others
Global Human Growth Hormone Market, By Route of Administration
Oral
Intravenous
Intramuscular
Subcutaneous
Global Human Growth Hormone market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive human growth hormone market market research and competitor analysis for your business to help you develop more profound insights into the human growth hormone market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the human growth hormone market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.